Last Friday’s ruling by a federal court in Washington, D.C., against Alere’s Arriva Medical subsidiary could help persuade the Delaware Chancery Court to allow Abbott Laboratoriesfeatured
A Delaware judge rejected pleas by Alere Inc. to schedule a fast trial over the company’s efforts to salvage its $5.8 billion acquisition by Abbott Laboratories, siding instead with Abbott’s request for an April court date. Alere had asked the court for an expedited trial beginningfeatured
Alere Inc., which is facing two federal criminal probes and also questions about its financial statements, has accused merger partner Abbott Laboratories of trying to scuttle their merger agreement because of “buyer’s remorse,” according to a lawsuit filed by Alere in Delaware Chancery Court and made public Wednesday. The Waltham, Massachusetts-based medical device maker also … Read Morefeatured
Simply fill out the form below and one of our representatives will be in touch.